Targeting disease at the intracellular level. Our small molecule platform is dedicated to discovering highly potent, orally bioavailable compounds capable of modulating critical disease pathways that larger therapies cannot reach.
Targeting disease at the intracellular level. Our small molecule platform is dedicated to discovering highly potent, orally bioavailable compounds capable of modulating critical disease pathways that larger therapies cannot reach.
